71888-24-9Relevant academic research and scientific papers
Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities
Wang, Pengxu,Batt, Sarah M.,Wang, Bin,Fu, Lei,Qin, Rongfei,Lu, Yu,Li, Gang,Besra, Gurdyal S.,Huang, Haihong
, p. 6241 - 6261 (2021/05/06)
In this study, we report the design and synthesis of a series of novel thiophene-arylamide compounds derived from the noncovalent decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1) inhibitor TCA1 through a structure-based scaffold hopping strategy. Systematic optimization of the two side chains flanking the thiophene core led to new lead compounds bearing a thiophene-arylamide scaffold with potent antimycobacterial activity and low cytotoxicity. Compounds 23j, 24f, 25a, and 25b exhibited potent in vitro activity against both drug-susceptible (minimum inhibitory concentration (MIC) = 0.02-0.12 μg/mL) and drug-resistant (MIC = 0.031-0.24 μg/mL) tuberculosis strains while retaining potent DprE1 inhibition (half maximal inhibitory concentration (IC50) = 0.2-0.9 μg/mL) and good intracellular antimycobacterial activity. In addition, these compounds showed good hepatocyte stability and low inhibition of the human ether-à-go-go related gene (hERG) channel. The representative compound 25a with acceptable pharmacokinetic property demonstrated significant bactericidal activity in an acute mouse model of tuberculosis. Moreover, the molecular docking study of template compound 23j provides new insight into the discovery of novel antitubercular agents targeting DprE1.
Diaryl 2- amide-substituted thiophene imide ester compound as well as preparation method and application thereof (by machine translation)
-
Paragraph 0153; 0157; 0160-0161; 0313; 0317; 0320-0321, (2020/02/17)
The invention also discloses a 2 - synthesis method thereof, and an application of the compound as an antibacterial agent, in the phthisis-caused by the bacterium, in particular to the, mycobacterium-induced infectious disease (especially (Tuberculosis,TB), mycobacterium- induced mycobacterium, tuberculosis), and (I) the invention, specifically relates to a pharmaceutical composition containing the compound of the present invention or, a R pharmaceutical composition comprising the compound of the present invention. 1 , R2 , R3 , R4 , R5 As described Y in the present invention. as described in the specification, the present invention is directed, to the preparation of novel compounds, having an anti-mycobacterial activity as potential, new drug (s) for the treatment (TB) or preventative treatment of infectious diseases, consisting of M. tuberculosis, in particular phthisis- caused by tubercular mycobacteria, while being useful in overcoming the problems associated with drug resistance. (by machine translation)
Spiro compounds or salts thereof and preventives/remedies for autoimmune diseases and AP-1 inhibitors containing the same
-
, (2008/06/13)
The spiro compounds of the present invention represented by the general formula: wherein A, R2, R3, R4, R5, R6and n are as defined in the specification, exhibit an AP-1 activity inhibitory action and, based on the AP-1 inhibitory action, suppresses the expression of a wide variety of genes and are useful as an agent for treating and preventing autoimmune diseases with lessoned side reactions.
The Tertiary Amide as an Effective Director of Ortho Lithiation
Beak, Peter,Brown, Roger A.
, p. 34 - 46 (2007/10/02)
The tertiary amides N,N-diethylbenzamide (1) and N,N-diisopropylbenzamide (3) give the ortho-lithiated species 2 on treatment with sec-BuLi/TMEDA or n-BuLi/TMEDA, respectively, at -78 deg.Lithiation of 1 followed by rection with either methyl iodide, ethyl iodide, benzophenone, acetone, benzaldehyde, or trimethoxyborane-hydrogen peroxide gives the expected ortho substituted product.Intramolecular competition between the diethyloamido and chloro, methoxyl, sulfonamido, (dimethylamino)methyl, or oxazolino functions in ortho- and para-substituted benzamides establishes the tertiary amido group to be more effective in directing metalation than any noncarboxamide functional group under the prescribed conditions.Complimentarity of directing effects is observed with the chloro and methoxyl groups in the meta-substituted diethylbenzamides but not with the methyl group.The secondary amide is found to have a directing ability comparable to the tertiary amide with sec-BuLi/TMEDA at -78 deg in THF although the yields are low. 13C NMR chemical shifts are particularly useful for the structural assignments which are confirmed chemically by lactonization of some products.A labeling study with N,N-diisopropyl-2,6-dideuteriobenzamide suggests that lithiation of the ortho position of 3 is direct and not the result of rearrangement of an initially formed α-aza anion.Control of metalation at the ortho or benzylic position by proper selection of the organolithium base is illustrated for N,N-diisopropyl-p-toluamide.The value of the tertiary amide for control of ortho lithiations and regiospecific aromatic substitutions is noted.
